Flagship Pioneering

@FlagshipPioneer

We’re a leading life sciences firm that conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability.

Cambridge, Massachusetts
Vrijeme pridruživanja: lipanj 2012.

Tweetovi

Blokirali ste korisnika/cu @FlagshipPioneer

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FlagshipPioneer

  1. Prikvačeni tweet

    ICYMI: Flagship Pioneering has launched Ohana™ Biosciences, an unprecedented biotechnology company that is revolutionizing reproductive health through sperm biology.

    Poništi
  2. proslijedio/la je Tweet
    2. velj

    Inside the Company That’s Developing the First Coronavirus Vaccine | Time ⁦⁩ ⁦

    Poništi
  3. 1. velj

    Apply for a Flagship Pioneering Fellowship: Where exceptional innovators help create the next generation of disruptive life science companies. Learn more and apply online:

    Poništi
  4. 31. sij
    Poništi
  5. proslijedio/la je Tweet
    28. sij
    Poništi
  6. proslijedio/la je Tweet
    30. sij

    Today marks an important milestone for Rubius and, more importantly, for the we hope to serve. We dosed our first patient in our Phase 1 clinical trial of RTX-134 for the treatment of .

    Poništi
  7. proslijedio/la je Tweet
    26. sij
    Poništi
  8. 27. sij

    We're proud to share that we unveiled a new company today: is revolutionizing the field of with the creation of the industry’s first biology platform. Learn more:

    Poništi
  9. 22. sij

    Kintai Therapeutics, a Flagship Pioneering company, today announced the advancement of a novel oral anti-obesity agent, showing sustained weight loss and improved markers of health in preclinical studies.

    Poništi
  10. proslijedio/la je Tweet
    20. sij
    Poništi
  11. 20. sij

    Depending on the needs of a patient, living drug factories could be implanted under the skin or in the abdomen. Depending on the needs of a patient, living drug factories could be implanted under the skin or in the abdomen.

    Poništi
  12. proslijedio/la je Tweet
    16. sij

    We were happy to present for the first time at Healthcare Conference this week. Wonderful connections, insightful takeaways, and invaluable exposure for Sigilon's novel approach to - That's a wrap!

    Poništi
  13. proslijedio/la je Tweet
    24. pro 2019.
    Poništi
  14. 16. sij

    The founder and CEO of Flagship Pioneering believes that pioneering is best done by teams, and that it is a process that can be taught, learned, and replicated. Read the Q&A with and Gary Pisano (a.k.a: )

    Poništi
  15. proslijedio/la je Tweet
    15. sij

    At shares the importance of incremental change in precision medicine in order to ultimately make transformative leaps in chronic disease innovation.

    Poništi
  16. proslijedio/la je Tweet
    13. sij

    has begun & we’re excited for our corporate presentation later this week! If you are doing any last-minute scheduling, be sure to mark your calendar for our session on Jan. 15th at 2:30 pm PST in the Elizabethan D Room at the Westin St. Francis Hotel

    Poništi
  17. 13. sij

    "We’re trying not to operate in a way that’s grounded in the present. We’re trying to say, 'Okay, what could exist?'"-- Can Breakthrough Innovations Be Made Systematically? A Conversation with Noubar Afeyan and Gary Pisano "

    Poništi
  18. proslijedio/la je Tweet
    12. sij

    This announcement is an important culmination of pioneering research conducted by the Moderna team. Congratulations to all.

    Poništi
  19. proslijedio/la je Tweet
    10. sij

    Today, we released our initial South American & production report for the the 2019/20 season. Currently, Indigo Atlas is predicting 12M fewer tons of corn and 19M fewer tons of soy than market consensus. Read our report & our commentary: .

    Poništi
  20. proslijedio/la je Tweet
    9. sij

    mRNA-1647 is the first vaccine for an to enter a Phase 2 clinical trial; Phase 2 data are expected in 2H 2020 & a Phase 3 study is expected to begin in 2021

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·